Javelin Pharmaceuticals, Inc. (AMEX:JAV), a leading developer of novel products for pain management, is presenting data today on its PMI-150 drug candidate (intranasal ketamine for acute pain) at the Department of Defense's (DoD) 2008 Advanced ...
Original post: Javelin Presents PMI-150 (Intranasal Ketamine For Acute Pain) Data At ... - Medical News Today
- Recent posts
- Relaxation exercises for pain management
- Jail for disability cheat who became a football referee - Guardian Unlimited
- Javelin Presents PMI-150 (Intranasal Ketamine For Acute Pain) Data At ... - Medical News Today
- Slip Disks In Back Pain Management
- HRT no quick fix for painful postmenopausal sex - Globe and Mail
- Medicinal Marijuana Effective For Neuropathic Pain In HIV - Medical News Today
- Utah Pain Management, Pain Management Utah, Utah Pain Doctor
- Equine acupuncture gaining popularity in central Florida - Herald Tribune
- NoHo Doctor wont face murder charges in overdose deaths - Los Angeles Daily News
- Pain Management by Julia [GENERAL]
- DJO Incorporated Announces Date for Release of Second Quarter 2008 ... - PR Inside
- Doctor - Anaesthesia Pain Management(Dublin (Ireland))
- Tips for pain management
- Imaging Study Of Pain Sheds Light On Mystery Condition - eMaxHealth.com
- ARCA biopharma Appoints James Carr as Vice President of Marketing - Forbes
- Jury acquits Gupta - Dayton Daily News
- New Medicade rules for hospice patients: ‘simple changes … big ... - Olympian
- Suffering and Chronic Pain Management
- Canadian Pain Society, mdBriefCase and AdvancingIn Team up to Provide ... - CNW Group
- Pain Relief